Nucleotide excision repair and B lymphoma: Somatic hypermutation is not the only culprit

Cell Cycle

Volumn 10, Issue 14, 2011, Pages 2276-2280

  Hyka Nouspikel, Nevila ^a   Nouspikel, Thierry ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Cancer stem cells; Carcinogenesis; Class switch recombination; Germinal center; Lymphoma; Mutagenesis; Nucleotide excision repair; Quiescence; Somatic hypermutation

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; TRANSCRIPTION FACTOR IIH;

ADAPTIVE IMMUNITY; ADULT STEM CELL; ANTIGENIC MODULATION; AUTOIMMUNITY; B CELL LYMPHOMA; B LYMPHOCYTE; CANCER STEM CELL; CANCER THERAPY; CELL DIVISION; DNA DAMAGE; DNA STRAND BREAKAGE; ENZYME ACTIVITY; EXCISION REPAIR; IMMUNOGLOBULIN GENE; LYMPHANGIOGENESIS; MUTAGENESIS; NONHUMAN; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; REVIEW; SOMATIC HYPERMUTATION; UBIQUITINATION; ULTRAVIOLET RADIATION;

EID: 79960470005     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.10.14.16496     Document Type: Review

References (50)

1. Kuppers R. Mechanisms of B-cell lymphoma pathogenesis. Nat Rev Cancer 2005; 5:251-62. (Pubitemid 40488631)
2. LeBien TW, Tedder TF. B lymphocytes: how they develop and function. Blood 2008; 112:1570-80.
3. Maul RW, Gearhart PJ. AID and somatic hypermutation. Adv Immunol 2010; 105:159-91.
4. Peled JU, Kuang FL, Iglesias-Ussel MD, Roa S, Kalis SL, Goodman MF, et al. The biochemistry of somatic hypermutation. Annu Rev Immunol 2008; 26:481-511. (Pubitemid 351600383)
5. Liu M, Duke JL, Richter DJ, Vinuesa CG, Goodnow CC, Kleinstein SH, et al. Two levels of protection for the B cell genome during somatic hypermutation. Nature 2008; 451:841-5. (Pubitemid 351253166)
6. Robbiani DF, Bothmer A, Callen E, Reina-San-Martin B, Dorsett Y, Difilippantonio S, et al. AID is required for the chromosomal breaks in c-myc that lead to c-myc/IgH translocations. Cell 2008; 135:1028-38.
7. Shen HM, Bozek G, Pinkert CA, McBride K, Wang L, Kenter A, et al. Expression of AID transgene is regulated in activated B cells but not in resting B cells and kidney. Mol Immunol 2008; 45:1883-92.
8. Okazaki IM, Hiai H, Kakazu N, Yamada S, Muramatsu M, Kinoshita K, et al. Constitutive expression of AID leads to tumorigenesis. J Exp Med 2003; 197:1173-81. (Pubitemid 36570072)
9. Muto T, Okazaki IM, Yamada S, Tanaka Y, Kinoshita K, Muramatsu M, et al. Negative regulation of activation-induced cytidine deaminase in B cells. Proc Natl Acad Sci USA 2006; 103:2752-7.
10. Robbiani DF, Bunting S, Feldhahn N, Bothmer A, Camps J, Deroubaix S, et al. AID produces DNA double-strand breaks in non-Ig genes and mature B cell lymphomas with reciprocal chromosome translocations. Mol Cell 2009; 36:631-41.
11. Pasqualucci L, Bhagat G, Jankovic M, Compagno M, Smith P, Muramatsu M, et al. AID is required for germinal center-derived lymphomagenesis. Nat Genet 2008; 40:108-12.
12. Hyka-Nouspikel N, Lemonidis K, Lu WT, Nouspikel T. Circulating human B lymphocytes are deficient in nucleotide excision repair and accumulate mutations upon proliferation. Blood 2011; 117:6277-6286.
13. Nouspikel T. DNA Repair in Mammalian Cells: Nucleotide excision repair: variations on versatility. Cell Mol Life Sci 2009; 66:994-1009.
14. Kraemer KH, Lee MM, Scotto J. Xeroderma pigmentosum. Cutaneous, ocular and neurological abnormalities in 830 published cases. Archives of dermatology 1987; 123:241-50.
15. Kraemer KH, Lee MM, Scotto J. DNA repair protects against cutaneous and internal neoplasia: evidence from xeroderma pigmentosum. Carcinogenesis 1984; 5:511-4. (Pubitemid 14126719)
16. Nouspikel T, Hanawalt PC. Terminally differentiated human neurons repair transcribed genes but display attenuated global DNA repair and modulation of repair gene expression. Mol Cell Biol 2000; 20:1562-70. (Pubitemid 30100176)
17. Hsu PS, Hanawalt PC, Nouspikel T. Nucleotide excision repair phenotype of human acute myeloid leukemia cell lines at various stages of differentiation. Mutat Res 2007; 614:3-15. (Pubitemid 44909214)
18. Nouspikel T, Hanawalt PC. DNA repair in terminally differentiated cells. DNA repair 2002; 1:59-75. (Pubitemid 34475693)
19. Nouspikel TP, Hyka-Nouspikel N, Hanawalt PC. Transcription domain-associated repair in human cells. Mol Cell Biol 2006; 26:8722-30. (Pubitemid 44851933)
20. Nouspikel T, Hanawalt PC. Impaired nucleotide excision repair upon macrophage differentiation is corrected by E1 ubiquitin-activating enzyme. Proc Natl Acad Sci USA 2006; 103:16188-93. (Pubitemid 44715172)
21. Nouspikel T. Multiple roles of ubiquitination in the control of nucleotide excision repair. Mech Ageing Dev 2011; DOI: 10.1016/j.mad.2011.03. 003.
22. McCulloch SD, Kunkel TA. The fidelity of DNA synthesis by eukaryotic replicative and translesion synthesis polymerases. Cell Res 2008; 18:148-61.
23. Kuppers R. The biology of Hodgkin's lymphoma. Nat Rev Cancer 2009; 9:15-27.
24. Chen L, Apgar J, Huynh L, Dicker F, Giago-McGahan T, Rassenti L, et al. ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia. Blood 2005; 105:2036-41. (Pubitemid 40731789)
25. Capello D, Vitolo U, Pasqualucci L, Quattrone S, Migliaretti G, Fassone L, et al. Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia. Blood 2000; 95:651-9. (Pubitemid 30041683)
26. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403:503-11. (Pubitemid 30082188)
27. Kuppers R, Klein U, Hansmann ML, Rajewsky K. Cellular origin of human B-cell lymphomas. N Engl J Med 1999; 341:1520-9. (Pubitemid 29526356)
28. Nouspikel T. DNA repair in differentiated cells: some new answers to old questions. Neuroscience 2007; 145:1213-21. (Pubitemid 46602722)
29. Peach HG, Barnett NE. Critical review of epidemiological studies of the association between smoking and non-Hodgkin's lymphoma. Hematol Oncol 2001; 19:67-80. (Pubitemid 32619227)
30. Morton LM, Hartge P, Holford TR, Holly EA, Chiu BC, Vineis P, et al. Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (interlymph). Cancer Epidemiol Biomarkers Prev 2005; 14:925-33. (Pubitemid 40478558)
31. Stagnaro E, Tumino R, Parodi S, Crosignani P, Fontana A, Masala G, et al. Non-Hodgkin's lymphoma and type of tobacco smoke. Cancer Epidemiol Biomarkers Prev 2004; 13:431-7.
32. Adami J, Gridley G, Nyren O, Dosemeci M, Linet M, Glimelius B, et al. Sunlight and non-Hodgkin's lymphoma: a population-based cohort study in Sweden. Int J Cancer 1999; 80:641-5. (Pubitemid 29066270)
33. Hall P, Rosendahl I, Mattsson A, Einhorn S. Non-Hodgkin's lymphoma and skin malignancies - shared etiology? Int J Cancer 1995; 62:519-22.
34. Ley RD. Photoreactivation of UV-induced pyrimidine dimers and erythema in the marsupial Monodelphis domestica. Proc Natl Acad Sci USA 1985; 82:2409-11. (Pubitemid 15064497)
35. Clydesdale GJ, Dandie GW, Muller HK. Ultraviolet light induced injury: immunological and inflammatory effects. Immunol Cell Biol 2001; 79:547-68. (Pubitemid 33070443)
36. Kripke ML. Ultraviolet radiation and immunology: something new under the sun - presidential address. Cancer Res 1994; 54:6102-5.
37. Wang L, Toda M, Saito K, Hori T, Horii T, Shiku H, et al. Post-immune UV irradiation induces Tr1-like regulatory T cells that suppress humoral immune responses. Int Immunol 2008; 20:57-70.
38. Brown EL, Rivas JM, Ullrich SE, Young CR, Norris SJ, Kripke ML. Modulation of immunity to Borrelia burgdorferi by ultraviolet irradiation: differential effect on Th1 and Th2 immune responses. Eur J Immunol 1995; 25:3017-22.
39. Kripke ML, Cox PA, Alas LG, Yarosh DB. Pyrimidine dimers in DNA initiate systemic immunosuppression in UV-irradiated mice. Proc Natl Acad Sci USA 1992; 89:7516-20.
40. Puebla-Osorio N, Miyahara Y, Coimbatore S, Limon-Flores AY, Kazimi N, Ullrich SE, et al. Induction of B-cell lymphoma by UVB radiation in p53 haploinsufficient mice. BMC Cancer 2011; 11:36.
41. Stary A, Kannouche P, Lehmann AR, Sarasin A. Role of DNA polymerase eta in the UV mutation spectrum in human cells. J Biol Chem 2003; 278:18767-75. (Pubitemid 36799258)
42. Toyama H, Okada S, Hatano M, Takahashi Y, Takeda N, Ichii H, et al. Memory B cells without somatic hypermutation are generated from Bcl6-deficient B cells. Immunity 2002; 17:329-39. (Pubitemid 35279553)
43. Shaffer AL, Yu X, He Y, Boldrick J, Chan EP, Staudt LM. BCL-6 represses genes that function in lymphocyte differentiation, inflammation and cell cycle control. Immunity 2000; 13:199-212.
44. Hase K, Takahashi D, Ebisawa M, Kawano S, Itoh K, Ohno H. Activation-induced cytidine deaminase deficiency causes organ-specific autoimmune disease. PLoS One 2008; 3:3033.
45. Straus SE, Jaffe ES, Puck JM, Dale JK, Elkon KB, Rosen-Wolff A, et al. The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood 2001; 98:194-200.
46. Hengge UR, Emmert S. Clinical features of xeroderma pigmentosum. Adv Exp Med Biol 2008; 637:10-8.
47. Lobo NA, Shimono Y, Qian D, Clarke MF. The biology of cancer stem cells. Annu Rev Cell Dev Biol 2007; 23:675-99.
48. Moore N, Lyle S. Quiescent, slow-cycling stem cell populations in cancer: A review of the evidence and discussion of significance. J Oncol 2011.
49. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer and cancer stem cells. Nature 2001; 414:105-11.
50. Passegue E, Jamieson CH, Ailles LE, Weissman IL. Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics? Proc Natl Acad Sci USA 2003; 100:11842-9.